Risk prediction score for high spinal block in patients undergoing cesarean delivery: a retrospective cohort study.
Pannawit Benjhawaleemas, Baramee Brahmasakha Na Sakolnagara, Jutarat Tanasansuttiporn...
https://pubmed.ncbi.nlm.nih.gov/39528929/Actively Recruiting
Led by Aswan University · Updated on 2026-08-26
666
Participants Needed
1
Research Sites
2 weeks
Total Duration
This research evaluates the impact of reducing the dose of intrathecal hyperbaric bupivacaine by 20% on the occurrence of high spinal block in women undergoing cesarean delivery. The trial is a prospective, randomized, double-blind, active-controlled study conducted in a single academic hospital setting. Participants are stratified by risk using a 7-factor model before randomization to better understand how well dose-aware versus dose-blind scoring predicts spinal block risk. Participants are randomly assigned to one of two groups the reduced-dose group receives 10 mg of hyperbaric bupivacaine combined with 25 mcg fentanyl, while the standard-dose group receives 12.5 mg of hyperbaric bupivacaine plus 25 mcg fentanyl. The spinal anesthesia is administered via a lumbar puncture with careful technique and positioning. Hemodynamic monitoring and safety protocols are followed during surgery without routine vasopressor use to avoid affecting the primary outcome. During the study, participants are closely monitored for sensory and motor block levels, heart rate, oxygen saturation, and blood pressure at frequent intervals up to surgery completion. Researchers assess the incidence of high spinal block within 15 minutes after drug administration as the primary outcome. Secondary outcomes include the accuracy of the risk prediction score, neonatal health shortly after birth, maternal satisfaction hours after surgery, and intraoperative hemodynamic stability. Total participation involves the surgery and immediate recovery period, with data collected up to about 2 hours post-anesthesia.
CONDITIONS
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery
E
Eman Mahmoud Ismail, Resident
S
Soudy Salah Hammad, consultant
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Aswan University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day
Participants receive spinal anesthesia with either the standard or a reduced dose of hyperbaric bupivacaine combined with fentanyl during cesarean delivery. They are positioned and monitored closely during surgery.
Continuous monitoring during surgery and immediate recovery
Duration - Up to 2 hours after surgery
Participants are observed for safety and recovery for up to about 2 hours post-anesthesia, including assessments of block level, hemodynamics, neonatal outcomes, and maternal satisfaction.
Monitoring at 5, 10, 15 minutes post-injection and periodically until discharge from post-anesthesia care
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Pannawit Benjhawaleemas, Baramee Brahmasakha Na Sakolnagara, Jutarat Tanasansuttiporn...
https://pubmed.ncbi.nlm.nih.gov/39528929/Aswan University
Lead Sponsor